Evommune, Inc.
EVMN
$18.87
-$0.02-0.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.06M | 86.80M | 48.41M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 3.78M | 6.60M | 5.91M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 2.10M | 1.50M | -- | -- | |
| Total Current Assets | 81.94M | 94.90M | 54.33M | -- | |
|
|
|||||
| Total Current Assets | 81.94M | 94.90M | 54.33M | -- | |
| Net Property, Plant & Equipment | 1.13M | 1.05M | 1.42M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 1.47M | 269.00K | 269.00K | -- | |
| Total Assets | 84.54M | 96.21M | 56.02M | -- | |
|
|
|||||
| Total Accounts Payable | 3.58M | 3.67M | 7.57M | -- | |
| Total Accrued Expenses | 6.31M | 5.92M | 4.63M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 504.00K | 424.00K | 644.00K | -- | |
| Total Finance Division Other Current Liabilities | 27.00K | 79.00K | 9.20M | -- | |
| Total Other Current Liabilities | 27.00K | 79.00K | 9.20M | -- | |
| Total Current Liabilities | 10.42M | 10.09M | 22.04M | -- | |
|
|
|||||
| Total Current Liabilities | 10.42M | 10.09M | 22.04M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 261.00K | 347.00K | 433.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | 6.00K | -- | |
| Total Liabilities | 10.68M | 10.44M | 22.48M | -- | |
|
|
|||||
| Common Stock & APIC | 9.68M | 9.11M | 8.54M | -- | |
| Retained Earnings | -192.82M | -180.34M | -166.78M | -- | |
| Treasury Stock & Other | -- | -1.00K | -- | -- | |
| Total Common Equity | -183.14M | -171.23M | -158.24M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 257.00M | 257.00M | 191.78M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 257.00M | 257.00M | 191.78M | -- | |
|
|
|||||
| Total Common Equity | -183.14M | -171.23M | -158.24M | -- | |
| Total Preferred Equity | 257.00M | 257.00M | 191.78M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 73.87M | 85.77M | 33.54M | -- | |
|
|
|||||